Home » Topics » BioWorld Science

BioWorld Science
RSS

MyoKardia opens phase III study of mavacamten in symptomatic obstructive hypertrophic cardiomyopathy

June 8, 2018

TET2 disruption improves antitumor activity of CAR T-cell therapy in a CLL patient

June 8, 2018

Roche patents anti-pY796-DDR1 antibodies

June 8, 2018

Mitochondrial aging in directly induced neurons may help understand neurodegenerative diseases

June 8, 2018

Seoul National University creates adenoviral vector encoding CRY1

June 8, 2018

FDA approves Mircera for pediatric use

June 8, 2018

Beijing Gegen Biotechnology, Yicon Medical Science and Technology Co. patent anti-EGFR antibodies

June 8, 2018

FDA grants orphan drug designation to olinciguat for sickle cell disease

June 8, 2018

Guangdong Longchuangji Pharmacy Co. presents Lactobacillus rhamnosus strain

June 8, 2018

FDA and EMA accepts regulatory submissions of talazoparib for review

June 8, 2018

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...